关注
Aru Narendran
Aru Narendran
Alberta Children's Hospital and The University of Calgary
在 ucalgary.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Tumour exosome integrins determine organotropic metastasis
A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, ...
Nature 527 (7578), 329-335, 2015
47032015
Profound block in thymocyte development in mice lacking p56lck
TJ Molina, K Kishihara, DP Siderovskid, W Van Ewijk, A Narendran, ...
Nature 357 (6374), 161-164, 1992
12051992
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4
A Rahemtulla, WP Fung-Leung, MW Schilham, TM Kündig, SR Sambhara, ...
Nature 353 (6340), 180-184, 1991
8421991
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive …
PM Miettunen, A Narendran, A Jayanthan, EM Behrens, RQ Cron
Rheumatology 50 (2), 417-419, 2011
3192011
Survivin as a preferential target for cancer therapy
M Mobahat, A Narendran, K Riabowol
International journal of molecular sciences 15 (2), 2494-2516, 2014
2432014
Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children
J Triscott, C Lee, C Foster, B Manoranjan, MR Pambid, R Berns, ...
Cancer research 73 (22), 6734-6744, 2013
1102013
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric …
R Bagatell, L Gore, MJ Egorin, R Ho, G Heller, N Boucher, EG Zuhowski, ...
Clinical Cancer Research 13 (6), 1783-1788, 2007
1092007
Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.
R Mader, A Narendran, J Lewtas, V Bykerk, RC Goodman, JR Dickson, ...
The Journal of Rheumatology 20 (8), 1429-1431, 1993
1081993
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice
C Lee, A Fotovati, J Triscott, J Chen, C Venugopal, A Singhal, C Dunham, ...
Stem cells 30 (6), 1064-1075, 2012
932012
Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro
M Sooriyaarachchi, A Narendran, J Gailer
Metallomics 3 (1), 49-55, 2011
902011
Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin
H Ganjavi, M Gee, A Narendran, N Parkinson, M Krishnamoorthy, ...
Cancer gene therapy 13 (4), 415-419, 2006
812006
A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes
T Spence, C Perotti, P Sin-Chan, D Picard, W Wu, A Singh, C Anderson, ...
Neuro-oncology 16 (1), 62-71, 2014
752014
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or …
TM Cooper, EAR Sison, SD Baker, L Li, A Ahmed, T Trippett, L Gore, ...
Pediatric blood & cancer 64 (8), e26414, 2017
742017
Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth
A Narendran, H Ganjavi, N Morson, A Connor, JW Barlow, E Keystone, ...
Experimental hematology 31 (8), 693-701, 2003
742003
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
S Tran, TH Truong, A Narendran
European journal of cancer 159, 259-274, 2021
682021
MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)
JC de Oliveira, MS Brassesco, CA Scrideli, LG Tone, A Narendran
Pediatric Blood & Cancer 59 (4), 599-604, 2012
542012
EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes
A Maddigan, L Truitt, R Arsenault, T Freywald, O Allonby, J Dean, ...
The Journal of Immunology 187 (11), 5983-5994, 2011
522011
Enzastaurin: A lesson in drug development
T Bourhill, A Narendran, RN Johnston
Critical reviews in oncology/hematology 112, 72-79, 2017
502017
The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro
M Sooriyaarachchi, A Narendran, J Gailer
Metallomics 4 (9), 960-967, 2012
502012
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin
H Ganjavi, M Gee, A Narendran, MH Freedman, D Malkin
Cancer Gene Therapy 12 (4), 397-406, 2005
482005
系统目前无法执行此操作,请稍后再试。
文章 1–20